JPJubilant Pharmova530019NCD issuance

Allotment of 80,000 NCDs aggregating Rs. 800 crore at 8.50% coupon on private placement basis

The company has allotted 80,000 Unsecured, Rated, Listed, Redeemable Non-Convertible Debentures (NCDs) of face value Rs. 1,00,000 each, issued at par, aggregating to Rs. 800 crore on a private placement basis to successful bidders.

By ScoutQuest · Thu 5 Nov 2026, 10:28 PM IST · 2 min read

NCD Issue Size

80,000 NCDs of face value Rs. 1,00,000 each, aggregating to Rs. 800 crore

Coupon Rate

8.50% p.a.

Tenure / Maturity

3 Years, maturing 05 November 2028

What was announced

• The Finance Committee of the company, at its meeting held on November 05, 2026, approved the allotment of 80,000 Unsecured, Rated, Listed, Redeemable Non-Convertible Debentures (NCDs) on a private placement basis to successful bidders.
• Each debenture has a face value of Rs. 1,00,000 and was issued at par, so the issue aggregates to Rs. 800 crore.
• This follows the company's earlier disclosure dated October 12, 2026 regarding the issuance of non-convertible debentures on a private placement basis.

Terms of the debentures

• Tenure: 3 Years. Date of allotment: 05 November 2026; date of maturity: 05 November 2028.
• Coupon/interest offered: 8.50% p.a.
• The debentures are proposed to be listed on BSE Limited.
• Charge/security created over the assets: None, as the instrument is unsecured.
• Special right/interest/privileges attached: Nil.
• The schedule of payment of coupon/interest and principal is as per the Key Information Document.

What it means for a retail investor

• The company has raised Rs. 800 crore of borrowings through this route. The coupon of 8.50% p.a. is the interest cost the company will pay on this debt until maturity in November 2028.
• Because the debentures are described as unsecured, they are not backed by a charge over the company's assets, and the update states there are no special rights attached.
• The instrument is proposed to be listed on BSE Limited, which means the debentures are intended to be tradable on the exchange.
• The company has noted Nil under any letter or comment regarding payment/non-payment of interest or principal, and redemption is to be done as per the tenure and maturity terms above.

Points to keep in mind

• This is a fund-raising event by the company, not a change in its equity share capital; NCDs are debt instruments.
• The cost of this borrowing to the company is the stated coupon of 8.50% p.a., payable as per the Key Information Document schedule.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev